Researchmoz Global Pvt. Ltd.

Global Regenerative Therapies Market - Asia Pacific & Japan to Witness Highest Growth by 2022


Albany, NY -- (SBWIRE) -- 10/10/2017 -- Regenerative therapies entail the application of specific types of cells or cell products for diseased tissues or organs, which ultimately help restore usual tissue and organ function. It also includes the possibility of growing tissues and organs in the laboratory and safely implanting them when the body cannot heal itself.

The regenerative therapies market holds major potential in the near future, which is attributed to the increasing application of these therapies in the treatment of various classes of diseases. The prime factor responsible for the same is the collaborative R&D efforts undertaken by researchers and manufacturers to develop and introduce newer and more efficient therapies. Orthopedic, cardiovascular, and soft tissue repair are the three main application segments in the global regenerative therapies market. Recently, there has been an alarming rise in the incidence rate of these disorders across the globe. Soft tissue repair and skin restoration therapies are currently the most widely adopted regenerative therapies globally.

Click to get sample PDF with TOC:

Surge in government support and funding from various organizations for R&D related to regenerative therapies over the last few years and increasing incidences of chronic diseases are among the major factors driving growth of the global regenerative therapies market currently.

The regenerative therapies market is segmented as follows:
- Regenerative Therapies Market, by Tissue Type
- Regenerative Therapies Market, by Application Type
- Regenerative Therapies Market, by End User
- Regenerative Therapies Market, by Region

This report covers the global regenerative therapies market performance in terms of revenue contribution from various segments. This section also includes PMRs analysis of the key trends, drivers, restraints and opportunities, which are influencing growth of the global regenerative therapies market currently. Impact analysis of the key growth drivers and restraints is also included in this report to better equip clients with crystal clear decision-making insights.

The regenerative therapies market report begins with an overview of the regenerative therapies procedures, covering the reasons why the patients are increasingly adopting these therapies. This section also underlines factors influencing growth of the regenerative therapies market currently, along with detailed analysis of the key trends, drivers, restraints, opportunities and regulations. Impact analysis of the key regional growth drivers and restraints based on the weighted average model, coupled with key region-specific trends, is included in report to better equip clients with information and hidden insights.

The global regenerative therapies market is segmented based on tissue type into allografts, xenografts, and alloplasts. Based on application type, the market has been segmented into soft tissue repair, cardiovascular, dental, orthopaedic, CNS disease treatment, and others. Based on end user, the market has been segmented into hospitals, ambulatory surgical centers, and educational institutes. A detailed analysis of every segment has been presented in terms of market size, Y-o-Y growth rate, absolute $ opportunity, market attractive index and BPS analysis. Among the various tissue types, allografts are expected to emerge as the product of choice both among surgeons and patients worldwide. Xenografts are also expected to gain popularity over the forecast period.

The next section of the report highlights the growth trends in the regenerative therapies market, by region. It provides the market outlook for 20162022 and sets the forecast within the context of the regenerative therapies market. The study discusses the key regional trends contributing to growth of the regenerative therapies market worldwide, as well as analyses the extent to which drivers are influencing this market in each region. Key regions assessed in this report include North America, Latin America, Europe, Asia Pacific and the MEA. North America is expected to emerge as the most dominant and most attractive market over the forecast period.


Key competitors in the market include:
- Acelity L.P. Inc.
- Mesoblast Ltd.
- Nuo Therapeutics, Inc. (Cytomedix).
- Astellas Pharma US, Inc.
- Organovo Holdings Inc.
- Orgenesis Inc.
- Sanofi.
- Athersys, Inc.
- Shire Pharmaceuticals Limited.
- Cytori Therapeutics Inc.
- Other.

About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:
Mr. Nachiket
Albany NY - 12207
United States
Tel: +1-518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Follow us on LinkedIn at: